Mark Adamchak - Oct 1, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Principal Accounting Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
4
Date filed
10/2/2024, 07:13 PM
Previous filing
Sep 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Oct 1, 2024 Common Stock 17.5K $0.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option vest on the one-year anniversary of the grant date.